On April 7, 2020 WIRED featured insights from AFAR expert Nir Barzilai, MD, on the potential of metformin as a drug already available on the market that could be used to fight COVID-19. Dr. Barzilai advocates for the testing of metformin and for taking a geroscience approach to the pandemic.
Dr. Barzilai is AFAR’s Scientific Director, a 1994 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient, a 1997 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar, a 2010 Irving S. Wright Award winner, and the Director at the Institute for Aging Research and distinguished Professor at the Albert Einstein College of Medicine.
Read the WIRED article, “Un-Miracle Drugs Could Help Tame the Pandemic,” here.
In the recent AFAR webinar, “COVID-19: Can the Science of Aging move us Forward?”, Dr. Barzilai presented on the potential of metformin in the fight against COVID-19 and why the AFAR-managed TAME Trial is more vital than ever in order to provide proof of concept that the biology of aging can be targeted through geroprotectors.
Watch Dr. Barzilai’s presentation from our recent AFAR webinar here.
Learn more about the upcoming TAME Trial here.
